On July 3, 2025, Ironwood Pharmaceuticals dismissed Ernst & Young LLP as their accounting firm due to a competitive review and appointed KPMG as the new firm; Ernst & Young reported material weaknesses in internal controls as of December 31, 2024, but no restatement of financial statements was needed.